Venture Life Group PLC (VLG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Venture Life Group PLC (VLG) has a cash flow conversion efficiency ratio of -0.012x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-955.00K ≈ $-116.20 USD) by net assets (GBX81.42 Million ≈ $9.91K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Venture Life Group PLC to measure how much of total assets are equity-financed.
Venture Life Group PLC - Cash Flow Conversion Efficiency Trend (2010–2025)
This chart illustrates how Venture Life Group PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Venture Life Group PLC's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Venture Life Group PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Venture Life Group PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
HTC Purenergy Inc.
V:HTC
|
0.006x |
|
Ristia Bintang Mahkotasejati
JK:RBMS
|
0.003x |
|
Vision Marine Technologies Inc
NASDAQ:VMAR
|
-0.157x |
|
Suumaya Industries Limited
NSE:SUULD
|
-0.016x |
|
Spectra Systems Corp
LSE:SPSY
|
-0.016x |
|
Biodexa Pharmaceticals
NASDAQ:BDRX
|
-0.204x |
|
Schroder European Reit Plc
LSE:SERE
|
0.022x |
|
Total Helium Ltd
V:TOH
|
0.006x |
Annual Cash Flow Conversion Efficiency for Venture Life Group PLC (2010–2025)
The table below shows the annual cash flow conversion efficiency of Venture Life Group PLC from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see VLG company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | GBX81.42 Million ≈ $9.91K |
GBX-264.00K ≈ $-32.12 |
-0.003x | -102.93% |
| 2024-12-31 | GBX75.41 Million ≈ $9.18K |
GBX8.35 Million ≈ $1.02K |
0.111x | +2.73% |
| 2023-12-31 | GBX76.25 Million ≈ $9.28K |
GBX8.22 Million ≈ $1.00K |
0.108x | +46.53% |
| 2022-12-31 | GBX75.66 Million ≈ $9.21K |
GBX5.57 Million ≈ $677.22 |
0.074x | +795.58% |
| 2021-12-31 | GBX73.16 Million ≈ $8.90K |
GBX601.00K ≈ $73.12 |
0.008x | -78.11% |
| 2020-12-31 | GBX72.11 Million ≈ $8.77K |
GBX2.71 Million ≈ $329.24 |
0.038x | -49.55% |
| 2019-12-31 | GBX32.82 Million ≈ $3.99K |
GBX2.44 Million ≈ $297.00 |
0.074x | +902.63% |
| 2018-12-31 | GBX32.08 Million ≈ $3.90K |
GBX238.00K ≈ $28.96 |
0.007x | +225.28% |
| 2017-12-31 | GBX14.19 Million ≈ $1.73K |
GBX-84.00K ≈ $-10.22 |
-0.006x | +81.40% |
| 2016-12-31 | GBX14.36 Million ≈ $1.75K |
GBX-457.00K ≈ $-55.60 |
-0.032x | +60.39% |
| 2015-12-31 | GBX13.80 Million ≈ $1.68K |
GBX-1.11 Million ≈ $-134.93 |
-0.080x | +43.47% |
| 2014-12-31 | GBX15.65 Million ≈ $1.90K |
GBX-2.22 Million ≈ $-270.60 |
-0.142x | +92.35% |
| 2013-12-31 | GBX557.00K ≈ $67.77 |
GBX-1.03 Million ≈ $-125.93 |
-1.858x | +54.27% |
| 2012-12-31 | GBX127.00K ≈ $15.45 |
GBX-516.00K ≈ $-62.78 |
-4.063x | -164.65% |
| 2011-12-31 | GBX312.00K ≈ $37.96 |
GBX-479.00K ≈ $-58.28 |
-1.535x | -30.19% |
| 2010-12-31 | GBX212.00K ≈ $25.79 |
GBX-250.00K ≈ $-30.42 |
-1.179x | -- |
About Venture Life Group PLC
Venture Life Group plc develops and commercializes healthcare products in the United Kingdom. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids. It also provides dermat… Read more